Ian F. Smith - Jan 3, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by Erin P. Brennan as attorney-in-fact for Ian F. Smith
Stock symbol
SLDB
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 04:22 PM
Previous filing
Jun 24, 2021
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +195K $0.00 195K Jan 3, 2022 Common Stock 195K $1.78 Direct F1
transaction SLDB Restricted Stock Units Award $0 +97.3K $0.00 97.3K Jan 3, 2022 Common Stock 97.3K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 3, 2022 pursuant to a services agreement between the reporting person and the Issuer and will vest in equal quarterly installments beginning three months from the date of the grant, with the final installment vesting 12 months from the date of the grant, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the option will accelerate in full.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.
F3 The restricted stock units were granted on January 3, 2022 and vest on the same schedule as set forth in footnote (1) above.